Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F3QZY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,714
Award facts
- Contract value 100% obligated
- $14,714.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,714.36 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL formulation. This non-competitive, firm fixed-price delivery order was awarded on December 9, 2025, with an ultimate completion date of December 10, 2025. The product will be performed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $999.99 billion ceiling value and extends through December 2026, positioning the contractor as a primary pharmaceutical vendor for military and federal healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive portfolio of federal contracts demonstrates capability in delivering a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative is planning multiple regional awards among several contractors, reflecting the strategic importance of reliable pharmaceutical supply chains for military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26F3QZY?
SPE2DR26F3QZY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F3QZY worth?
The government has obligated $14,714 on SPE2DR26F3QZY.
Is contract SPE2DR26F3QZY an order under another contract?
Yes. SPE2DR26F3QZY is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3QZY competed?
The extent of competition for SPE2DR26F3QZY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award